NCT05003323

Brief Summary

This case-control study in patients with knee osteoarthritis and pain-free control individuals aims to develop a brain biomarker of endogenous analgesia that may be used in subsequent clinical trials. Deficits in central nervous system (CNS) pain inhibition may contribute to chronic pain intensity, but quantitative sensory testing (QST) methods are limited. Incorporating brain imaging to assessments of CNS pain inhibition, by examining activity in relevant brain networks, would allow for an objective, physiologic measure of CNS pain inhibition. Preliminary data in pain-free volunteers implicate cortical activity measured with functional near-infrared spectroscopy (fNIRS) during CNS pain inhibition. Broadly, the investigators hypothesize that variability in CNS pain inhibition contributes to variability in clinical pain intensity.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
110

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Nov 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 6, 2021

Completed
6 days until next milestone

First Posted

Study publicly available on registry

August 12, 2021

Completed
3 months until next milestone

Study Start

First participant enrolled

November 18, 2021

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 20, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 20, 2023

Completed
Last Updated

January 13, 2025

Status Verified

January 1, 2025

Enrollment Period

1.9 years

First QC Date

August 6, 2021

Last Update Submit

January 9, 2025

Conditions

Outcome Measures

Primary Outcomes (4)

  • Differences in offset analgesia

    Pain intensity difference during offset and control heat stimuli

    15 minutes

  • Differences in brain region activation- QST

    Difference in brain region activation (as measured by oxygenated hemoglobin, HbO) between CNS inhibition and control stimuli during QST procedures.

    2-3 hours

  • Differences in brain region activation- walking test

    Change in brain region activation (HbO) between rest and ambulation during the 6 minute walking test test

    15 minutes

  • Differences in brain region activation- stair climbing

    Change in brain region activation (HbO) between rest and ambulation during the stair climbing test

    15 minutes

Secondary Outcomes (19)

  • Differences in resting fNIRS signaling

    5-10 minutes

  • QST battery responses

    2-3 hours

  • Pain intensity scores after stair climbing task

    10 minutes

  • Pain intensity scores after walking test

    6 minutes

  • Duration of stair climbing task

    10 minutes

  • +14 more secondary outcomes

Study Arms (3)

High Knee Pain with Osteoarthritis

Adults 45-80 years old who have moderately severe knee osteoarthritis and rate their daily knee pain at \>=6 on a 0-10 numeric rating scale

Low Knee Pain with Osteoarthritis

Adults 45-80 who have moderately severe knee osteoarthritis and rate their daily knee pain at \<=5 on a 0-10 numeric rating scale

Healthy Controls

Age matched, BMI matched adults who do not have knee osteoarthritis or chronic pain

Eligibility Criteria

Age45 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Participants will be recruited from the Pitt+Me registry which comprises of any members of the local population who are registered in the program.

You may qualify if:

  • For the knee arthritis groups: Chronic knee pain with evidence of knee osteoarthritis - radiographically grades 2-4
  • Age: 45-80 years old
  • Gender: Males and females will be recruited.
  • Language: only English-speaking subjects will be included.

You may not qualify if:

  • Inflammatory arthritis (e.g. rheumatoid arthritis)
  • Inability to walk and climb stairs unassisted
  • History of knee replacement or open knee surgery
  • History of arthroscopic knee surgery within the last 3 months (\>3 months does not exclude participant)
  • History of knee radiofrequency nerve ablation or ligation
  • Current opioid use
  • Current use of antidepressants that are not in the serotonin-selective reuptake inhibitor (SSRI) class. Patients who are currently using an SSRI are allowed to take part in the study
  • Cognitive impairment affecting the ability to provide informed consent, understand directions, and participate in study procedures
  • Uncontrolled or unstable medical disorder preventing participation in study procedures
  • History of brain surgery
  • Tattoos on forearm or knee
  • Pregnancy
  • Patients with chronic pain conditions that are more severe than their knee arthritis pain (e.g., CRPS, fibromyalgia)
  • Patients whose most painful knee is excluded for another reason (e.g., recent surgery on most painful knee)
  • For the pain-free control group: a history of chronic pain
  • +1 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UPMC Pain Medicine at Centre Commons

Pittsburgh, Pennsylvania, 15206, United States

Location

Related Publications (1)

  • Alter BJ, Maurer M, O'Connell B, Sanchez AG, Kaynar AM, DiGioia AM, Huppert T, Wasan AD. Deficits in temporal pain inhibition are associated with greater pain and functional impairment in osteoarthritis. Pain. 2025 Nov 1;166(11):2490-2509. doi: 10.1097/j.pain.0000000000003648. Epub 2025 Jun 19.

MeSH Terms

Conditions

Chronic PainOsteoarthritis, KneeAgnosia

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsOsteoarthritisArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic DiseasesPerceptual DisordersNeurobehavioral ManifestationsNervous System Diseases

Study Officials

  • Benedict Alter, MD, PhD

    University of Pittsburgh

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

August 6, 2021

First Posted

August 12, 2021

Study Start

November 18, 2021

Primary Completion

October 20, 2023

Study Completion

October 20, 2023

Last Updated

January 13, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will not share

Locations